首页> 美国卫生研究院文献>other >A new murine model of early onset autoimmune thyroiddisease/hypothyroidism and autoimmune exocrinopathy of the salivarygland
【2h】

A new murine model of early onset autoimmune thyroiddisease/hypothyroidism and autoimmune exocrinopathy of the salivarygland

机译:新型早发性自身免疫性甲状腺的鼠模型唾液疾病/甲状腺功能减退和自身免疫性外分泌病腺

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

60–70 % of IFN-γ−/− NOD.H-2h4 mice given NaI-supplemented water develop a slow onset autoimmune thyroid disease, characterized by thyrocyte epithelial cell hyperplasia/ proliferation (TEC H/P). TEC H/P develops much earlier in CD28−/− mice and nearly 100 % (both sexes) have severe TEC H/P at 4 months of age. Without NaI supplementation, 50% of 5–6 month old CD28−/−IfFN-γ−/− mice develop severe TEC H/P, and 2–3 weeks of NaI is sufficient for optimal development of severe TEC H/P. Mice with severe TEC H/P are hypothyroid and normalization of serum thyroxine (T4) levels does not reduce TEC H/P. Activated CD4+ T cells are sufficient to transfer TEC H/P to SCID recipients. Thyroids of mice with TEC H/P have infiltrating T cells and expanded numbers of proliferating thyrocytes that highly express CD40. CD40 facilitates, but is not required for development of severe TEC H/P, as CD40−/−IFN-γ−/−CD28−/− mice develop severe TEC H/P. Accelerated development of TEC H/P inIFN-γ−/−CD28−/− mice is a result of reduced Treg numbersas CD28−/− mice have significantly fewer Tregs, andtransfer of CD28-positive Tregs inhibits TEC H/P. Essentially all femaleIFN-γ−/−CD28−/−NOD.H-2h4 mice have substantiallymphocytic infiltration of salivary glands and reduced salivary flow by 6months of age, thereby providing an excellent new model of autoimmuneexocrinopathy of the salivary gland. This is one of very few models whereautoimmune thyroid disease and hypothyroidism develop in most mice by 4 monthsof age. This model will be useful for studying the effects of hypothyroidism onmultiple organ systems.
机译:补充NaI的水中60-70%的IFN-γ-// NOD.H-2h4小鼠发展为缓慢发作的自身免疫性甲状腺疾病,其特征是甲状腺细胞上皮细胞增生/增殖(TEC H / P )。 TEC H / P在CD28 -/-小鼠中的发育要早得多,并且几乎100%(男女)在4个月大时都有严重的TEC H / P。如果不添加NaI,5-6个月大的CD28 -// I fFN-γ-// 小鼠中有50%会出现严重的TEC H / P,并需要2-3周NaI的量足以优化重症TEC H / P的最佳发展。 TEC H / P严重的小鼠为甲状腺功能减退,血清甲状腺素(T4)水平正常化不会降低TEC H / P。活化的CD4 + T细胞足以将TEC H / P转移至SCID受体。具有TEC H / P的小鼠的甲状腺具有浸润性T细胞和数量众多的高表达CD40的增殖性甲状腺细胞。 CD40有助于但不严重的TEC H / P的形成,因为CD40 -/-IFN-γ-/- CD28 -/-小鼠出现严重的TEC H / P。加速TEC H / P的开发IFN-γ-/-CD28 -/-小鼠是Treg数量减少的结果因为CD28 -/-小鼠的Treg明显减少,并且CD28阳性Treg的转移会抑制TEC H / P。基本上所有女性IFN-γ-/-CD28 -/- NOD.H-2h4小鼠唾液腺的淋巴细胞浸润和唾液流量减少了6月龄,从而提供了出色的自身免疫新模型唾液腺外分泌病。这是极少数的型号之一大多数小鼠在4个月内会出现自身免疫性甲状腺疾病和甲状腺功能减退症年龄。该模型将有助于研究甲状腺功能减退对多器官系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号